Suppression of microRNA-27a protects against liver ischemia/reperfusion injury by targeting PPARγ and inhibiting endoplasmic reticulum stress
Suppression of microRNA-27a protects against liver ischemia/reperfusion injury by targeting PPARγ and inhibiting endoplasmic reticulum stress
复制标题
DOI:
10.3892/mmr.2019.10645
复制
发表时间:
2019-11-01
影响因子:
3.4
通讯作者:
Zhang, Xiaojin
中科院分区:
文献类型:
--
作者:
Chi, Xiaobin;Jiang, Yi;Zhang, Xiaojin
Liver ischemia-reperfusion (I/R) injury is an important clinical issue related to liver transplantation. Recent studies suggest that microRNAs are implicated in various biological and pathological processes, including liver I/R injury. This study aimed to investigate the role and potential mechanism of miR-27a during liver I/R injury. A liver I/R model was induced via 60 min of ischemia and reperfusion for 6 h in rats. Cells were transfected with miR-27a mimics or the miR-27a inhibitor to examine the effect of miR-27a on liver I/R. Apoptotic cells were detected by flow cytometry and TUNEL staining. The expression of miR-27a was measured by real-time PCR. The expression of peroxisome proliferator-activated receptor gamma (PPAR gamma); gastrin-releasing peptide 78 (GRP78) and C/EBP homologous protein (CHOP) were detected by western blot analysis. The results showed that miR-27a was significantly upregulated during I/R injury in vivo and in vitro. In addition, miR-27a inhibitors attenuated hypoxia/reoxygenation (H/R)-induced oxidative stress, endoplasmic reticulum stress (ERS) and apoptosis in AML12 cells. By contrast, miR-27a mimics promoted hypoxia/reoxygenation-induced ERS, and apoptosis. Furthermore, PPAR gamma was identified as a target gene of miR-27a using bioinformatic analysis and a dual-luciferase reporter assay. Knockdown of PPAR gamma significantly abrogated the inhibitory effect of miR-27a inhibitors on the ERS pathway. Moreover, the miR-27a antagomir attenuated liver I/R injury in rats, a finding manifested by reduced ALT/AST, hepatocyte apoptosis, oxidative stress and inhibition of the ERS pathway. Taken together, these findings demonstrate that suppression of miR-27a protects against liver I/R injury by targeting PPAR gamma and by inhibiting the ERS pathway.